1. Antiemetic treatment for cancer chemotherapy: problems and progress

   • R. J. Gralla

   Editorial Pages: 275 - 276

2. Supportive care news

   • F. Stiefel

   News Pages: 277 - 278

3. Antiemetics in children receiving cancer chemotherapy

   • A. L. Billett
   • S. E. Sallan

   Special Article Pages: 279 - 285

4. Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT₃ receptor antagonists

   • P. J. Hesketh

   Review Article Pages: 286 - 292

5. Are there differences among the serotonin antagonists?

   • M. Tonato
   • F. Roila
   • A. Del Favero

   Review Article Pages: 293 - 296

6. Delayed emesis following anticancer chemotherapy

   • M. G. Kris
   • K. M. W. Pisters
   • L. Hinkley

   Review Article Pages: 297 - 300

7. Future of the management of emesis

   • Steven M. Grunberg

   Review Article Pages: 301 - 303

8. Costs and benefits of antiemetic therapy

   • M. S. Aapro

   Review Article Pages: 304 - 306

9. Costs and benefits of outpatient therapy

   • E. B. Rubenstein

   Review Article Pages: 307 - 311

10. New developments in the assessment of pain in cancer patients

    • F. Bruera
    • S. Watanabe

    Review Article Pages: 312 - 318

11. Overview of current development in patient-controlled analgesia

    • Celeste Lindley

    Review Article Pages: 319 - 326

12. MASCC in New Orleans, USA “The 6th International Symposium on Supportive Care in Cancer”, March 2–5, 1994

    • L. Boussauw

    Meeting Highlights Pages: 327 - 327

13. Forthcoming meetings

    Announcement Pages: 328 - 329